SEC Info - China Jo-Jo Drugstores Holdings, Inc.

SEC Info℠

Home

Help

Please Sign In

China Jo-Jo Drugstores Holdings, Inc. – ‘6-K’ for 4/6/22

On: Wednesday, 4/6/22, at 9:15am ET · For: 4/6/22 · Accession #: 1213900-22-18327 · File #: 1-40724

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/06/22  China Jo-Jo Drugstores Holdi… Inc 6-K         4/06/22    2:22K                                    EdgarAgents LLC/FA

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Report of Foreign Private Issuer                    HTML     10K 
 2: EX-99.1     Press Release Dated April 6, 2022, Announcing the   HTML      8K 
                Company Will Effect Its 1-For-12 Reverse Stock                   
                Split

‘6-K’ — Report of Foreign Private Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2022

Commission File Number: 001-40724

CHINA JO-JO DRUGSTORES, INC.
(Translation of registrant’s name into English)

Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District,

Hangzhou City, Zhejiang Province, People’s Republic of China, 310008
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

China Jo-Jo Drugstores, Inc., a Cayman Islands company (the “Company”) furnishes under the cover of Form 6-K the following:

Exhibit No.		Description of Exhibit
99.1		Press Release dated April 6, 2022, announcing the Company will effect its 1-for-12 Reverse Stock Split.

C: 1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 6, 2022	CHINA JO-JO DRUGSTORES, INC.

	By:	/s/ *Lei Liu*
	Name:	Lei Liu
	Title:	Chief Executive Officer

Dates Referenced Herein

This ‘6-K’ Filing	Date	Other Filings

Filed on / For Period end:	4/6/22	None on these Dates
		List all Filings

8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/29/24  China Jo-Jo Drugstores, Inc.      424B5                  1:768K                                   EdgarAgents LLC/FA
 9/26/23  China Jo-Jo Drugstores, Inc.      424B5                  1:806K                                   EdgarAgents LLC/FA
 1/23/23  China Jo-Jo Drugstores Holdi… Inc 424B5                  1:796K                                   EdgarAgents LLC/FA
 1/11/23  China Jo-Jo Drugstores Holdi… Inc F-3                    5:578K                                   EdgarAgents LLC/FA
11/23/22  China Jo-Jo Drugstores Holdi… Inc F-3/A                  1:754K                                   EdgarAgents LLC/FA
10/19/22  China Jo-Jo Drugstores Holdi… Inc F-3/A                  2:779K                                   EdgarAgents LLC/FA
 9/15/22  China Jo-Jo Drugstores Holdi… Inc F-3/A                  5:842K                                   EdgarAgents LLC/FA
 8/05/22  China Jo-Jo Drugstores Holdi… Inc F-3/A                  2:747K                                   EdgarAgents LLC/FA

↑Top

Filing Submission 0001213900-22-018327 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)